Endocardial Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

Ulrich Sigwart · The Lancet · 1995 · 790 citations

Cardiac Muscle, Cardiomyopathy, Non-surgical Myocardial Reduction +4

Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience

H. Kuhn, Thorsten Lawrenz, Frank Lieder et al. · Clinical Research in Cardiology · 2007 · 132 citations

Transcoronary Ablation, Cardiac Muscle, Cardiomyopathy +8

Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy

Valerian Fernandes, Christopher D. Nielsen, Sherif F. Nagueh et al. · JACC: Cardiovascular Interventions · 2008 · 108 citations

Alcohol Septal Ablation, Heart Failure, Cardiomyopathy +3

One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response

Lothar Faber, Dirk Welge, H. K. Schmidt et al. · Clinical Research in Cardiology · 2007 · 81 citations

Cardiomyopathy, Cardiogenic Shock, Clinical Response +7

Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion

H. Kuhn · European Heart Journal · 1999 · 57 citations